Skip to main content

Table 2 Baseline patient demographics

From: Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Study

Mean Age

Female

Diabetes Mellitus

Hypertension

Dyslipidemia

Current Smoker

Previous PCI

Need for oral anticoagulation

Clinical presentation

Non-adherence rate

GLOBAL LEADERS

65

23%

25%

74%

70%

26%

33%

Exclusion

criteria

Stable angina: 53%

NSTEMI: 21%

STEMI: 13%

Experimental arm: 27%

Control arm: 13%

MASTER DAPT

76

31%

33%

77%

68%

9%

26%

33%

Stable angina: 40%

NSTEMI: 25%

STEMI: 12%

Experimental arm: 2%

Control arm: 0.4%

SHORTDAPT-2

69

22%

39%

74%

75%

24%

34%

Exclusion criteria

Stable angina: 62%

NSTEMI: 6%

STEMI: 19%

Experimental arm: 0.1%

Control arm: None

One-month DAPT

67

31%

38%

67%

82%

17%

17%

Exclusion criteria

Stable angina: 62%

Unstable angina: 37%

Experimental arm: 18%

Control arm: 4%

  1. PCI percutaneous coronary intervention, NSTEMI non-ST segment elevation myocardial infarction, STEMI ST-segment elevation myocardial infarction